SCHEMBL19986426

SCHEMBL19986426

CC(C)CNCc1cc(CN(C)C)c(O)c(CN(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CYP2C9 P11712 1/20 0.49
HTT P42858 2/20 0.45
CYP2C19 P33261 1/20 0.45
MAPK1 P28482 1/20 0.45
ALDH1A1 P00352 5/20 0.44
GSR P00390 1/20 0.41
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 2/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
G6PD P11413 1/20 0.40
PABPC1 P11940 1/20 0.40
HKDC1 Q2TB90 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19986424 0.90 ALOX15 (0.41) ALOX15HSD17B10CYP2C9HTTCYP2C19
SCHEMBL18095789 0.88 HSD17B10 (0.46) ALOX15HSD17B10CYP2C9HTTCYP2C19
SCHEMBL18095788 0.85 ALOX15 (0.44) ALOX15HSD17B10CYP2C9HTTCYP2C19
SCHEMBL19986425 0.81 ALOX15 (0.43) ALOX15HSD17B10CYP2C9HTTCYP2C19
SCHEMBL18095784 0.79 ALOX15 (0.51) ALOX15HSD17B10CYP2C9HTTCYP2C19
SCHEMBL30119839 0.75 OPRD1 (0.35) ALOX15HSD17B10CYP2C9ALDH1A1GSR
SCHEMBL18095782 0.75 ALOX15 (0.46) ALOX15HSD17B10CYP2C9HTTCYP2C19
SCHEMBL5038968 0.75 HSD17B10 (0.53) ALOX15HSD17B10CYP2C9HTTCYP2C19
SCHEMBL36297 0.74 HSD17B10 (0.80) ALOX15HSD17B10CYP2C9HTTCYP2C19
SCHEMBL25306052 0.73 HSD17B10 (0.77) ALOX15HSD17B10CYP2C9HTTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180079710-A1 AMINE FOR RAPID-CURING EPOXY RESIN COMPOSITIONS SIKA TECHNOLOGY AG (CH) 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180079710-A1 AMINE FOR RAPID-CURING EPOXY RESIN COMPOSITIONS EEF1A1, KDM5B, SEM1 ALOX15 476/4885HSD17B10 3990/4885CYP2C9 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.